Dermata Therapeutics Inc. Warrant (DRMAW) financials
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Dermata Therapeutics Inc. Warrant income statement, balance sheet, and cash flow from the statement cache. Years sit on this URL — not a year mill.
| Line | FY2022 |
|---|---|
| Net Income | -$2.79M |
| EPS (Diluted) | -$5.35 |
| Line | FY2022 | FY2021 |
|---|---|---|
| Total Assets | $6.94M | $11.6M |
| Cash & Equivalents | $6.24M | $10.8M |
| Total Liabilities | $922.6K | $1.52M |
| Line | FY2025 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$6.43M | -$4.62M |
| Financing Cash Flow | $7.93M | $7.94M |
FAQ
What is DRMAW revenue?
DRMAW income-statement cache has no revenue figure yet.
Is DRMAW profitable?
Dermata Therapeutics Inc. Warrant last cached net income is -$2.79M (FY2022).
What are DRMAW total assets?
Dermata Therapeutics Inc. Warrant last cached total assets are $6.94M (FY2022).
What is DRMAW free cash flow?
No cached cash-flow row for DRMAW yet.
Not investment advice. Cached statements, not a live tape.